Catalyst Pharmaceuticals, Inc.
NCM: CPRX📈 ZcoreAI Score
Our AI model analyzes Catalyst Pharmaceuticals, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get CPRX Z-Score →About Catalyst Pharmaceuticals, Inc.
📊 Fundamental Analysis
Catalyst Pharmaceuticals, Inc. demonstrates exceptional profitability, with a profit margin of 36.4%.
The company recently reported 7.6% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 25.5%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $24.94, CPRX currently sits at the 78th percentile of its 52-week range (Range: $19.05 - $26.58).
💰 Valuation Insight
CPRX trades at a 40.6% discount (PE: 14.85), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.